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ABSTRACT
Objectives: Uterine artery Doppler is frequently used in the first trimester and it is one of the more effective measurement 
methods in the prediction of preeclampsia and intrauterine growth restriction (IUGR). Progesterone is a hormone that is 
used quite frequently in various indications in obstetrics and gynecologic practice. We aimed to investigate the influence 
of progesterone on the uterine artery Doppler pulsatility index (PI) at 11–14 gestational weeks.
Material and methods: This study is a retrospective case-control study conducted in Selcuk University Faculty of Medicine 
between January and December 2019. Uterine artery Doppler PI values of patients using progesterone were compared with 
PI values of patients not using progesterone. Uterine artery PI was measured two times, left and right. Then the mean PI 
was calculated. All measurements were made by two operators and by the same ultrasonography machine
Results: A total of 288 patients, 140 patients using progesterone and 148 patients not using progesterone were included 
in the study. Demographic characteristics were similar between the groups (p > 0.05). There were no significant differences 
between the groups in the right and left uterine artery PI values. There was no significant difference for average uterine 
artery PI between the groups (p < 0.05).
Conclusions: Progesterone has no significant influence on uterine artery PI. However, more prospective studies in which 
all potential confounding factors are considered including serum progesterone levels are needed for this subject.
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INTRODUCTION
Many functional and structural uterine vascular system 
changes occur in pregnancy. The basis of the changes in the 
uterine artery is the trophoblastic invasion of the spiral arter-
ies, and these changes provide the fetus with a greater blood 
supply [1]. Incorrect changes in the spiral arteries may cause 
insufficient uteroplacental perfusion and this may lead to 
some complications, such as intrauterine growth restriction 
(IUGR), preeclampsia, spontaneous preterm delivery, and 
premature rupture of membranes [1, 2].
Preeclampsia is an important life-threatening disease 
for both the mother and fetus. The pathogenesis of this 
disease occurs as a result of a defect in the trophoblastic 
invasion of the placenta in the first trimester of pregnancy 
[2]. Preeclampsia is the most important cause of maternal 
and fetal morbidity and mortality in both developed and 
developing countries [3]. Unfortunately, there is still no ef-
fective treatment other than delivery. Due to the increased 
fetal morbidity and mortality, especially in preterm pregnan-
cies, preeclampsia prediction is very important. Many ultra-
sonographic and biochemical evaluations of preeclampsia 
predictions have been defined in the literature [4–6]. Uter-
ine artery Doppler is a well-known diagnostic method for 
the prediction of preeclampsia [6, 7]. The uterine artery 
Doppler pulsatility index (PI) is used for the prediction of 
preeclampsia during the 11th–14th gestational weeks. Many 
studies indicate that preeclampsia development is more fre-
quent in women with high uterine artery PI [6–10]. External 
factors affecting PI values of uterine artery Doppler have 
been investigated previously in the literature. The effects 
of parameters such as patient position and emptiness/full-
ness of bladder were explored [11, 12]. The relationship 
between progesterone use and uterine artery Doppler at 
the 11th–14th gestational weeks has not been specifically 
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investigated in the literature. Progesterone is one of the 
main hormones in pregnancy, and it is used very often in 
obstetric practice. Therefore, we aimed to investigate the 
effect of progesterone use on uterine artery Doppler PI at 
the 11th–14th gestational weeks.
MATERIAL AND METHODS
This study is a retrospective case-control study con-
ducted in Selcuk University Faculty of Medicine between 
January and December 2019. It was approved by the local 
ethics committee and conducted in accordance with the 
principles of the Helsinki Declaration (Reg.No:2020/022).
The patients between 18–45 years old and who had 
singleton pregnancy at 11 + 0 to 13 + 6 weeks of gestation 
with a normal fetus, without having systemic disease and 
treatment except vitamins, and using vaginal micronized 
progesterone for more than one week were included into 
the study. The exclusion criteria were the presence of hy-
pertension, diabetes, vasculopathy, preeclampsia history, 
multiple pregnancies, usage of aspirin, and anticoagulant 
drug. Uterine artery Doppler PI values of progesterone us-
ers were compared with PI values of patients who were not 
using progesterone. 
Uterine artery Doppler measurement
In our clinic, first trimester uterine artery Doppler is 
measured at 11–14 gestational weeks. The midsagittal sec-
tion of the uterus and cervical canal is determined using 
transabdominal ultrasound. After the internal cervical canal 
is recognized, the uterine artery is determined by shifting 
the probe to both paracervical areas. During the measure-
ment, it is acceptable to have 100–150 cc of urine in the 
bladder. When three similar consecutive waveforms are 
obtained, the right and left uterine artery PI values are re-
corded. It was measured two times, left and right. Then the 
mean PI was calculated. All measurements were made by 
two operators (NM and EÇ) and by the same ultrasonogra-
phy machine. (LOGIQ F8, General Electric Co.; Milwaukee, WI, 
USA). 95th percentile of the mean UA PI of the present study 
lied similar within the ranges recorded by Gómez et al. [13].
Statistical Analysis
Statistical analysis was performed using the Statistical 
Package for the Social Sciences (SPSS) version 21.0 soft-
ware package (IBM Corp., Armonk, NY, USA). A histogram 
curve and Shapiro–Wilk analysis were used to check for 
normal distribution. Descriptive statistics are expressed in 
mean ± standard deviation (SD), median (min-max), and 
number, where appropriate. Data were analyzed using 
the Mann–Whitney U test, Student’s t-test, and Pearson’s 
chi-squared test. P values of < 0.05 were considered statisti-
cally significant.
RESULTS
A total of 288 patients, 140 progesterone using pa-
tients and 148 patients not using progesterone were in-
cluded in the study. All of the patients using progesterone 
in our study were patients using drugs due to the threat 
of miscarriage. There was no significant difference for 
age between the groups (mean 28.7 ± 5.0 vs 28.8 ± 5.01; 
p = 0.885). Gestational age was no significant difference 
between the groups [median 12 (11–13) vs 12 (11–13); 
p = 0.224]. Gravida and parity were similar between the 
groups (p > 0.05). There were no significant differences be-
tween the groups in terms of the right and left uterine artery 
PI values (mean 1.70 ± 0.46 vs 1.81 ± 0.51; p = 0.062, and 
mean 1.72 ± 0.52 vs 1.73 ± 0.40; p = 0.843; respectively). There 
was no significant difference for average uterine artery PI be-
tween the groups (mean 1.71 ± 0.40 vs 1.77 ± 0.37; p = 0.184). 
In five patients, the average uterine artery PI value was found 
to be greater than the 95th percentile (p > 0.05) (Tab. 1).
DISCUSSION
Progesterone is a hormone that has a very important 
function both in the regulation of the menstrual cycle and in 
pregnancy. Progesterone is also one of the most commonly 
prescribed drugs during pregnancy. Uterine artery Dop-
pler, measured between 11–14 weeks, has also been used 
recently in the prediction of preeclampsia. However, the 
interaction of these two conditions has not been specifically 
investigated in the literature. In our study, we found that 
the use of progesterone had no effect on bilateral uterine 
artery PI.
The uterine artery is one of the main vessels of the uterus 
and fetus. During pregnancy, the spiral arteries are exposed 
to remodeling for providing enough blood supply to the 
Table 1. Demographic and uterine artery Doppler data according 







Age 28.7 ± 5.0 28.8 ± 5.01 0.885*
Gestational age 12 (11–13) 12 (11–13) 0.224*
Gravida 2 (1–6) 2 (1–6) 0.740+
Parity 1 (0–4) 0 (0–5) 0.899+
RUA.PI 1.70 ± 0.46 1.81 ± 0.51 0.062*
LUA.PI 1.72 ± 0.52 1.73 ± 0.40 0.843*
AUA.PI 1.71 ± 0.40 1.77 ± 0.37 0.184*
AUA.PI > 95th centile 4 (2.9%) 1 (0.7%) 0.157**
Data are given as mean (± SD), number (%) or median (minimum-maximum) 
where appropriate; *Independent Simple t-test; +Mann–Whitney U test; 
**Pearson’s chi-squared test; PI — pulsatility index; RUA.PI — right uterine 
artery PI; LUA.PI — left uterine artery PI; AUA.PI — average uterine artery PI
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fetus. Makikalio et al. demonstrated that in uncomplicated 
pregnancies, a progressive decrease began in the spiral artery 
PI at the fifth week gestation [14]. The impaired remodeling 
process can result in further pregnancy complications such 
as IUGR or pregnancy-induced hypertension.  There are many 
studies claiming that these changes in the uterine artery 
can be used to predict preeclampsia [6, 7]. In a meta-analysis 
of Velauthan et al. on about 55,000 pregnant women, they 
found that first-trimester uterine artery Doppler was a use-
ful tool for predicting early-onset pre-eclampsia and other 
adverse pregnancy outcomes [15]. In the present study, we 
investigated whether a common agent such as progesterone 
had a confounding effect on uterine artery Doppler. We found 
no effect of progesterone use on uterine artery Doppler PI.
Progesterone is used quite frequently in various indica-
tions in obstetrics and gynecologic practice. Although the 
effect of progesterone on the uterine artery in non-pregnant 
women is known, there is limited and conflicting infor-
mation in the literature regarding its effect on pregnant 
women. Micronized progesterone is frequently used during 
pregnancy, it has a direct effect on the uterus and has higher 
concentrations in the uterine tissue. In addition, its vaginal 
form is superior to the oral form; although it reaches a faster 
plasma peak level in oral intake, more constant drug concen-
trations are observed in vaginal use [16, 17]. Progesterone 
is effectively used for the prevention of threatened miscar-
riage, preterm labor, preterm birth in women with a short 
cervix, luteal deficiency, and recurrent miscarriage [18–23]. 
Czajkowski et al. [24] found that vaginal progesterone 
administration resulted in a decrease in spiral artery PI in 
early pregnancy complicated by threatened abortion. In ad-
dition, they found that vaginal progesterone treatment was 
associated with a significant decrease in the spiral artery PI 
after 2 weeks’ and 4 weeks’ treatment. In a study conducted 
by Jamal et al. [25] on pregnant women at 18–20 weeks of 
gestation, it was found that the use of progesterone and 
aspirin had a significant effect on uterine artery PI, 
and they found that vaginal progesterone use suppressed the 
resistance of uterine artery. Maged et al. [26] found that the use 
of progesterone for one week in patients in the third trimester 
had no significant effects on uterine artery PI. In this study, our 
hypothesis was that progesterone use might be a confounding 
factor on the uterine artery PI while predicting preeclampsia 
in the first trimester, but it was shown that progesterone use 
had no significant effect on uterine artery Doppler.
The retrospective design, unknown serum progester-
one levels, and lack of long-term follow-up outcomes are 
limitations of this study. The strength of this study is that 
the effect of progesterone, a hormone commonly used at 
11–14 weeks of gestation, on uterine artery Doppler, has 
not been investigated previously.
CONCLUSIONS
In conclusion, progesterone has no significant effect 
on uterine artery PI at 11–14 weeks of gestation. However, 
prospective studies are needed for this issue, where all po-
tential confounding effects are considered, such as serum 
progesterone levels.
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